Dexcom Inc (NASDAQ:DXCM) shares traded -1.10% lower at $69.05 on Wall Street last session.
DXCM stock price is now -22.71% away from the 50-day moving average and -40.40% away from the 200-day moving average. The market capitalization of the company currently stands at $27.67B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $161 to $80, Robert W. Baird Downgraded its rating from Outperform to Neutral for Dexcom Inc (NASDAQ: DXCM). On July 26, 2024, JP Morgan Downgraded its previous ‘Overweight’ rating to ‘Neutral’ on the stock reducing its target price from $145 to quote $75, while ‘Redburn Atlantic’ rates the stock as ‘Neutral’
In other news, Brown Michael Jon, EVP, Chief Legal Officer sold 686 shares of the company’s stock on Aug 30 ’24. The stock was sold for $48,020 at an average price of $70.00. Upon completion of the transaction, the EVP, Chief Legal Officer now directly owns 65,636 shares in the company, valued at $4.53 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 30 ’24, Officer MICHAEL BROWN bought 686 shares of the business’s stock. A total of $48,020 was incurred on buying the stock at an average price of $70.00. A total of 1.41% of the company’s stock is owned by insiders.
During the past 12 months, Dexcom Inc has had a low of $62.34 and a high of $142.00. As of last week, the company has a debt-to-equity ratio of 1.07, a current ratio of 2.82, and a quick ratio of 2.48. According to the stock market information, the enterprise value for the company is $27143786496, which is based on a 42.55 price-to-earnings ratio, a 2.63 price-to-earnings-growth ratio, and a beta of 1.18. The fifty day moving average price for DXCM is $89.3356 and a two-hundred day moving average price translates $115.85755 for the stock.
The latest earnings results from Dexcom Inc (NASDAQ: DXCM) was released for 2024-06-30. The net profit margin was 16.95% and return on equity was 29.41% for DXCM. The company reported revenue of $1.0 billion for the quarter, compared to $871.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.26 percent.
